ING Groep NV Purchases 4,133 Shares of Teleflex Incorporated (NYSE:TFX)

ING Groep NV raised its position in Teleflex Incorporated (NYSE:TFX) by 20.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 24,334 shares of the medical technology company’s stock after buying an additional 4,133 shares during the quarter. ING Groep NV’s holdings in Teleflex were worth $4,331,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Simplify Asset Management Inc. bought a new stake in shares of Teleflex during the 3rd quarter valued at $4,800,000. JPMorgan Chase & Co. grew its position in Teleflex by 14.3% during the third quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after buying an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in Teleflex by 5.2% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock worth $19,263,000 after buying an additional 5,322 shares in the last quarter. Lecap Asset Management Ltd. purchased a new position in Teleflex during the fourth quarter worth about $729,000. Finally, Mirae Asset Global Investments Co. Ltd. grew its position in Teleflex by 35.1% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after buying an additional 1,527 shares in the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Price Performance

TFX opened at $175.43 on Friday. The stock’s 50 day simple moving average is $177.07 and its 200 day simple moving average is $207.80. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a 1 year low of $165.62 and a 1 year high of $249.90. The firm has a market cap of $8.15 billion, a price-to-earnings ratio of 34.88, a PEG ratio of 1.73 and a beta of 1.16.

Analysts Set New Price Targets

TFX has been the subject of several recent analyst reports. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Truist Financial cut their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. Royal Bank of Canada cut their price objective on Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Finally, Mizuho cut their price objective on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.